Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease.
about
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseCurrent Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.Neuropsychological contributions to the early identification of Alzheimer's disease.Alzheimer's disease is type 3 diabetes-evidence reviewed.Alzheimer's disease--one clinical syndrome, two radiological expressions: a study on blood pressure.Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's diseaseBrain metabolic dysfunction at the core of Alzheimer's disease.Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirmed Alzheimer's disease.Relationships between diabetes and cognitive impairmentThe effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease.Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapiesThe 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.
P2860
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
P2860
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease.
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease.
@ast
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease.
@en
type
label
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease.
@ast
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease.
@en
prefLabel
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease.
@ast
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease.
@en
P2093
P356
P1476
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease
@en
P2093
Brad Gemelli
Bradley T. Hyman
Dannie Etiene
E. Tessa Hedley-Whyte
Jack R. Wands
Joanny Kraft
Neema Ganju
Suzanne M. De La Monte
Teresa Gomez-Isla
P304
P356
10.3233/JAD-1998-1205
P577
1998-12-01T00:00:00Z